The makers of Xarelto are accusing the plaintiffs who are currently suing over the dangerous side effects of the blood thinner of trying to manipulate the group of cases selected for trial and filling the docket with claims that never should have been filed in the first place.

Defendants Johnson & Johnson and Bayer AG claim that the plaintiffs are using bellwether manipulation that is most likely to win rather than representative cases.

However, the plaintiffs and their Xarelto attorneys said recently that the trial selections for the bellwether program have been atypical of the majority of the cases inside the mass tort program but the proposed case management order highlights cases that represent approximately two-thirds of the docket.

If you’ve been seriously injured by Xarelto, consult with the Xarelto attorneys at McDonald Worley today. 

Xarelto Attorneys Can Help with Defective Drug Claims

The mass tort program filed by plaintiffs with the help of Xarelto attorneys was created in January 2017 to consolidate all related cases that were pending in Philadelphia county.

Many of the claims lodged by Xarelto attorneys on the plaintiff’s behalf accused Janssen and Bayer of failing to appropriate warn consumers about the risk of bleeding linked with the medication and failure to include appropriate details about the importance of proper monitoring and dose adjustments by physicians.

Litigation was proceeding under a second master complaint filed in 2016 and that initial trial ended with a high multimillion dollar verdict that was thrown out on post-trial motions.

The most recent trial led to jurors rejecting claims that the warning labels for the drug left out key information about the increased risk of the drug when it was combined with other types of medication.

Those plaintiffs who are critically injured might have no other alternative than to pursue help with Xarelto attorneys. The plaintiffs responded to these allegations that they chose misrepresentative cases by alleging that defendants made misleading statements to the court in order to sway the judge to use an unfair selection process.

Johnson & Johnson and Bayer recently filed a motion outlining the process that they would like the court to use by selecting cases that will be tried across 2018.

Their filing alleges that the plaintiffs are regularly dismissing trial pool cases in order to choose ones more favorable to plaintiffs rather than those cases that are representative of the more than 1,800 lawsuits currently pending in Philadelphia.

Plenty of cases are expected to be added to the list of people who were harmed by Xarelto in the near future as well.

If you’ve been seriously injured by Xarelto, consult with the Xarelto attorneys at McDonald Worley today.